Advanced Search

Oncology & Hematology Coding Alert

Oncology/Hematology Coding:

Understand This MUE and How to Override It

Published on Thu Mar 05, 2026

Question: Our provider ordered 180 mg of lanreotide on the same date of service (DOS) for a Medicare patient, which has a Medically Unlikely Edit (MUE) of 120 mg. How should I submit a claim for this drug, and if the claim gets denied, how should I appeal? AAPC Forum Participant Answer: You are correct in saying that the outpatient [...]
Codify by AAPC
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

Subscribe to newsletter